A Shutdown Ending Could Trigger a Relief Rally in Cryptos

When U.S. government shutdowns end, there's often a relief rally that gives cryptos a massive boost. But this time, according to Juan Villaverde, Ethereum could be the biggest winner, with these three smaller cryptos also benefiting. If the shutdown officially ends, you will want to be positioned early.

SNGX
Soligenix Inc
NASDAQ
1.36
Open 1.41 Prev Close 1.42
High 1.44 Low 1.35
Volume 118,347 Volume (Avg) 4,123
52 Week High 6.23 52 Week Low 1.09
Market Cap 13.7M PE Ratio

Shares Stats

Shares Outstanding9,860,000
Shares Float9,840,000
Shares Short590,000
Insider Holdings16%
Institution Holdings2.40%

About Soligenix Inc

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in Phase 3 clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX945, an IDR technology that is in Phase 2a study to treat aphthous ulcers in Behçet's disease; and SGX302, an IDR technology, which is in Phase 2a study for the treatment of mild-to-moderate psoriasis. Its Public Health Solutions segment engages in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a, 1b, and 1c clinical trials; SGX943, a therapeutic candidate in preclinical studies for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; CiVax, a vaccine candidate for the prevention of COVID-19; and vaccine programs that target filoviruses, such as Marburg and Ebola. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.

General

NameSoligenix Inc
TickerSNGX
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees14

Highlights

Analyst Target10.00
Market Cap13,700,000
PEG Ratio-1.52
EBITDA-12,080,094

Financials

Curr Year EPS Estimate-2.15
Next Quarter EPS Estimate-0.47
Return on Assets-0.69
Return on Equity-1.65
Earnings Per Share-3.06
Quarterly Revenue Growth-1

Valuation

Price/Sales (Trailing 12 Mt.)3,874.85
Price/Book (Most Recent Quarter)6.22

Earnings

Most Popular

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.

Michael Caine and Matthew McConaughey partner with ElevenLabs for AI voice cloning

NEW YORK (AP) — Oscar-winning actors Michael Caine and Matthew McConaughey have made deals with voice-cloning company ElevenLabs that will allow its artificial intelligence technology to replicate their voices.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Time To Sell XRP? These 3 Indicators Scream 'Take Profits'

XRP (CRYPTO: XRP) fell below key moving averages on Wednesday, signaling fading bullish momentum as multiple indicators flashed a strong sell warning.

Vietnam's VinFast Hits Over 20,000 Monthly EV Deliveries

VinFast delivered a record 20,380 EVs in Vietnam in October—first local maker to top 20k in a month—even as shares dipped.

The Real Brains Behind AI Machines - Ad

AI needs more than algorithms. It needs hardware that can think and move - without melting your data center. This one company designs the most efficient chips on the planet, used in billions of devices. And it just helped launch new AI processors for data centers and robotics.

JPMorgan Raises Forecast On This Warren Buffett Favorite Oil Stock

JP Morgan raises Occidental Petroleum (OXY) price target to $51 after Q3 earnings beat, noting capital reallocation from OxyChem and Low Carbon Ventures to upstream projects.

The Real Reason This Analyst Still Calls Nebius His Favorite Neocloud Player

Nebius Group (NASDAQ: NBIS) reported strong Q3 results, boosting capacity & revenue guidance through 2026. Analyst reiterated Buy rating.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It

November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.

Forget Amazon's 1997 IPO... This Could Be 287 Times Bigger - Ad

Since Amazon's IPO in 1997, it climbed enough to turn $100 into $250,000. Now, one man says Elon Musk could be gearing up to take his internet satellite giant public... in what Fortune magazine says will be the biggest IPO in history! James Altucher is sharing how ANYONE can get a pre-IPO stake... with as little as $100!

Ford Expedition vs GMC Yukon, an Edmunds big SUV comparison

Let’s say you need a vehicle with room for more than five passengers, a large cargo area, and the ability to pull a heavy trailer. A full-size three-row SUV should work well, but which one? The most significant news this year is the redesigned . Ford has given its biggest SUV a complete makeover with a more upscale interior, new technology features and a novel split-opening tailgate.

FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.

Former Illinois Farmboy Built a Weird A.I. System to Expose His Wife's Killer... Now It's About to Transform the World - Ad

After his wife's untimely death, he used Artificial Intelligence to get sweet revenge... But what happened next could change everything... while making a select few early investors very rich.

How Europe's private drone industry eyes opportunity as NATO strengthens defense

AALBORG, Denmark (AP) — In a warehouse more than 1,500 kilometers (900 miles) from Ukraine's capital, workers in northern Denmark painstakingly piece together . Some of the devices will be exported to Kyiv in the hopes of jamming Russian technology on the battlefield, while others will be shipped across Europe in efforts to combat mysterious drone intrusions into NATO's airspace that have the entire continent on edge.

Best ETF For The Critical Minerals Boom? Here Are Rare Earth Winners

Here's how VanEck's REMX and Amplify's BATT stack up in the fight for dominance over critical minerals and the clean energy supply chain.

Nvidia Is Too Expensive. This One Powers More Devices. - Ad

Everyone's chasing Nvidia. But this company's chip designs are in billions more devices - and it trades for a fraction of the price. It just inked major AI deals... and Wall Street is only just starting to notice. It may be the best pure play AI stock yet.

The Latest: Trump set to arrive in Japan, where he'll meet new Prime Minister Takaichi

U.S. arrives Monday in Japan where he’ll meet new for the first time. She’s a protege of late Prime Minister Shinzo Abe, who Trump bonded with over their shared love of golf.

Shutdown stalemate set to drag into sixth week as Trump pushes Republicans to change Senate rules

WASHINGTON (AP) — Republicans and Democrats remained at a stalemate on the over the weekend as it headed into its sixth week, with for millions of Americans and President Donald Trump pushing GOP leaders to change Senate rules to end it.

The Next Biggest Bull Run In Over 50 Years - Ad

Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Taiwan Didn't Steal US Chip Jobs, It Helped Create Them, Says Tech Insider

Taiwan Semiconductor Manufacturing Co stands at the heart of global chip production, powering US tech giants and fueling growth.

Cathie Wood Bets Big On Jack Dorsey's Bitcoin-Heavy Block, Adds Amazon And Alibaba — Sells Shopify, Surging Palantir

On Monday, Cathie Wood-led Ark Invest executed significant trades, including a notable purchase of shares in Amazon.com Inc. (NASDAQ:AMZN), Block Inc.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

The stock market is breaking records. Time for a gut check

NEW YORK (AP) — Almost everything in your 401(k) should be coming up a winner now. That makes it time for a gut check.

Elon Musk's Tesla Records $80 Million Paper Profit On Bitcoin In Q3, Keeps Holdings Intact

Tesla Inc. (NASDAQ:TSLA) held on to its Bitcoin (CRYPTO: BTC) for another quarter, reporting its second consecutive paper profit from cryptocurrency holdings.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.

Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

Datadog Posts 'Great' Q3 Beat, Analysts Praise 'Compounding Growth Ahead'

Shares of Datadog came under pressure in early trading on Friday, despite the company Thursday reporting upbeat third-quarter results.

A Shutdown Ending Could Trigger a Relief Rally in Cryptos - Ad

When U.S. government shutdowns end, there's often a relief rally that gives cryptos a massive boost. But this time, according to Juan Villaverde, Ethereum could be the biggest winner, with these three smaller cryptos also benefiting. If the shutdown officially ends, you will want to be positioned early.

Tesla's Q3 Earnings Divide Analysts, But Dan Ives Says 'The Worst Is In The Rearview Mirror' For The 'Most Undervalued' Name In AI

Tesla Inc.'s (NASDAQ: TSLA) third-quarter results have sparked a range of reactions from Wall Street, with some analysts calling the report a turning point and others urging caution on near-term expectations.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Nasdaq Surges Over 100 Points, Records Gains In October: Greed Index Remains In 'Fear' Zone

CNN Money Fear and Greed index remained in Fear zone on Friday. US stocks closed higher, Nasdaq up 4.7% in October. Amazon reported earnings.

Why Is Phio Pharmaceuticals Stock Soaring Today?

Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medical trial.

The Real Brains Behind AI Machines - Ad

AI needs more than algorithms. It needs hardware that can think and move - without melting your data center. This one company designs the most efficient chips on the planet, used in billions of devices. And it just helped launch new AI processors for data centers and robotics.

Ford's enormous F-150 becomes unlikely part of Japan's efforts to woo Trump

TOKYO (AP) — Japan's most iconic truck might be the tiny white transport vehicles that farmers use to lug gear on the narrow roads that link their rice fields.

Cathie Wood Bets $21 Million On Robinhood, Snaps Up Netflix — Sells These Two Hot AI Stocks

Ark Invest made significant trades involving Robinhood, Netflix, AMD, and Palantir. These trades reflect Ark's strategic positioning amidst market indicators and corporate developments.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Alaska Airlines says an information technology outage is grounding its flights

SEATTLE (AP) — An information technology outage has prompted Alaska Airlines to ground its planes, the airline said Thursday.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service